
Pharmacist and Senior Vice President - Quality and Safety @stjuderesearch
Joined August 2009
- Tweets984
- Following921
- Followers831
- Likes4K
James Hoffman retweeted
Hot off the press!
ASHP Pharmacy Forecast 2025: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems academic.oup.com/ajhp/articl…
James Hoffman retweeted
New postdoc position is available in my lab!
Looking for motivated candidates interested in joining a team seeking to advance the treatment of patients with infections caused by difficult-to-treat fungal pathogens (C. auris and Mucorales).
Apply now : talent.stjude.org/careers/jo…
James Hoffman retweeted
Five key points from the 2023 #drug expenditures report @AJHPOfficial @ASHPOfficial academic.oup.com/ajhp/articl…
James Hoffman retweeted
Always great listening to @JesseSwen talk about the UPGx project and implementation of Pharmacogenomics in Europe #PGx. @pgrnhub meeting
James Hoffman retweeted
A great end to today’s packed presentation agenda, important findings of the PREPARE study presented by Dr. @JesseSwen #PGRN2023
James Hoffman retweeted
Implementation science is a relatively new field. Solving complex problems. Applying a systematic method. It also has to include those who are really close to the problem. - Dr. Amar Shah of NHS Foundation Trust #IHISummerCamp
James Hoffman retweeted
.@jamesmhoffman kicks off today’s #IHISummerCamp webinar, “Improving Care, Improving Lives Together.” The panel will explore how improvement science methods can be embedded across the continuum to improve efficiency of research and discovery. @TheIHI
James Hoffman retweeted
I will be presenting the multidimensional model of quality session B5 today at 13:15 auditorium 15 @QualityForum #Quality2023
Join me and hear about the need to rethink how we define quality and coproduce care @krisvanhaecht
James Hoffman retweeted
For 2023, @Sudamonas & colleagues expect overall #PrescriptionDrugSpending to rise by 6-8%, whereas in clinics & hospitals, they anticipate increases of 8-10% and 1-3%, respectively.
Read the full report in @AJHPOfficial: ow.ly/UXn250O6srR
James Hoffman retweeted
National trends in prescription #drug #expenditures and projections for 2023 @AJHPOfficial @ASHPOfficial academic.oup.com/ajhp/advanc…
James Hoffman retweeted
Our annual US drug forecast paper is out. To celebrate we updated our top 15 drug animation!
@AJHPOfficial @eric_tichy @Sudamonas @jamesmhoffman @UICPharmDean
Take a peak and number 2....
#drugpricing
What are the latest drivers of 💊spending? What was the top selling drug in 2022?
🆕paper from this team of experts (including CP3's @Sudamonas) answers these questions and looks ahead to the rest of 2023.
@AJHPOfficial
academic.oup.com/ajhp/advanc…
James Hoffman retweeted
What are the latest drivers of 💊spending? What was the top selling drug in 2022?
🆕paper from this team of experts (including CP3's @Sudamonas) answers these questions and looks ahead to the rest of 2023.
@AJHPOfficial
academic.oup.com/ajhp/advanc…
James Hoffman retweeted
Are pediatric EHR implementations associated with an increase in hospital-acquired conditions? Not according to this new study using @sps4kids data published in @ACI_Journal - h/t @NaveedRabbaniMD @StanfordKidCMIO @jamesmhoffman (cc @ACIFellows)
thieme-connect.com/products/…
James Hoffman retweeted
Replying to @HH_Oncodr @pashtoonkasi
@HH_Oncodr actual cost of a DPYD genotyping test is $174, not $1500. DPYD testing is a cost effective way to prevent fatal toxicity. Once you get the process implemented it becomes quite routine.
pubmed.ncbi.nlm.nih.gov/3566…
James Hoffman retweeted
Pharmacy Forecast 2023: Balancing the urgency of now versus strategy for tomorrow. academic.oup.com/ajhp/articl…
James Hoffman retweeted
We congratulate Dr. Cyrine Haidar, named @BPSweb chair-elect. @cyrineeliana is a founding member of the Pharmacogenomics Research Network and St. Jude clinical pharmacogenomics senior program manager. https://nitter.cf/t.co/rJQmJTxhFB #PharmSci
James Hoffman retweeted
An amazing team and institution to work with for anyone interested in Clinical Pharmacogenomics and Medication Safety ⬇️
Interested in working with the Clinical Pharmacogenomics and Medication Use Safety Teams at St. Jude to help advance and improve treatment of children with catastrophic diseases? If you are, check out this job posting and apply! talent.stjude.org/careers/jo…
James Hoffman retweeted
Our newest Fall 2022 edition of DiscoveRx is filled with stories about leaders in #pharmacy practice, research, and education, including a newly discovered family of lipid transfer proteins and a first-of-its-kind specialty pharmacy service. 🔽
discoverx.pharmacy.wisc.edu/…
James Hoffman retweeted
CPIC guidelines for prescribing medications in patients with G6PD deficiency have been updated & now cover use of 40+ drugs. Many drugs formerly considered high-risk are now deemed safe. Read the latest. https://nitter.cf/t.co/Tll9NyMJhZ @mrelling @ASCPTjournals #pharmacogenetics @cpicpgx
James Hoffman retweeted
A great article for anyone wondering how to counsel patients on PGx testing or how others do it.
New #research from ACCP PK/PD/PG PRN members Teresa Ho, @roseanngammal, and @DunnenbergerPGX addresses the important topic of effective patient counseling approaches when communicating panel-based #pharmacogenetics results. Full article available at: academic.oup.com/ajhp/advanc…




























